Biodef Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 129.13%
(FY 2021)
- Profit 14.94%
(FY 2021)
- Ebitda 14.96%
(FY 2021)
- Net Worth 32.61%
(FY 2021)
- Total Assets 25.14%
(FY 2021)
About Biodef Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parvez Alam and Gulista Chandni serve as directors at the Company.
- CIN/LLPIN
U85300DL2014PTC265424
- Company No.
265424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biodef Healthcare Private Limited offer?
Biodef Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Syrup, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Eye Drops, Ayurvedic Herbal Syrups & Tonics, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Biodef Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvez Alam  | Director | 26-Feb-2014 | Current |
| Gulista Chandni | Director | 19-Jun-2015 | Current |
Financial Performance of Biodef Healthcare.
Biodef Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 129.13% increase. The company also saw a substantial improvement in profitability, with a 14.94% increase in profit. The company's net worth Soared by an impressive increase of 32.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biodef Healthcare?
In 2021, Biodef Healthcare had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biodef Healthcare?
Unlock and access historical data on people associated with Biodef Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biodef Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biodef Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
